Ananda Pharma (STU:1FX) Receivables Turnover: (As of Jul. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ananda Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Ananda Pharma's Revenue for the six months ended in Jul. 2025 was €0.01 Mil. Ananda Pharma's average Accounts Receivable for the six months ended in Jul. 2025 was €0.00 Mil.

Ananda Pharma  (STU:1FX) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Ananda Pharma Receivables Turnover Related Terms

Ananda Pharma Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Ananda Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Receivables Turnover Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Receivables Turnover
Get a 7-Day Free Trial - - - - -

Ananda Pharma Semi-Annual Data
Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:1FX vs ZTS, UTHR, VTRS: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ananda Pharma Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's Receivables Turnover falls into.


Ananda Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Ananda Pharma's Receivables Turnover for the fiscal year that ended in Jan. 2025 is calculated as

Receivables Turnover (A: Jan. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Jan. 2025 ) / ((Accounts Receivable (A: Jan. 2024 ) + Accounts Receivable (A: Jan. 2025 )) / count )
=0.001204881316726 / (( + ) / 1 )
=0.001204881316726 / 0
=N/A

Ananda Pharma's Receivables Turnover for the quarter that ended in Jul. 2025 is calculated as

Receivables Turnover (Q: Jul. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Jul. 2025 ) / ((Accounts Receivable (Q: Jan. 2025 ) + Accounts Receivable (Q: Jul. 2025 )) / count )
=0.0060636736418231 / (( + ) / 1 )
=0.0060636736418231 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Business Description

Address 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).